Serial Number
97539845
Owner
Elsie Biotechnologies Inc.Attorney
Christopher M. HanesFiling Date
Aug 8, 2022
ELSIE BIOTECHNOLOGIES Trademark
Serial Number: 97539845
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
10355 Science Center Drive, Suite 110
San Diego, CA 92121
Entity Type: 03
Legal Representation
Correspondence Address
Christopher M. Hanes GSK
410 Blackwell Street
Legal Brand Protection
Durham, NC 27701
United States
Trademark Details
Filing Date
August 8, 2022
Registration Date
Not Registered
Published for Opposition
December 19, 2023
Goods & Services
Oligonucleotide compounds for use as pharmaceutical therapies prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents that facilitate delivery of a wide range of pharmaceutical therapies prescribed or administered by a physician; Oligonucleotide-based or -derived pharmaceuticals prescribed or administered by a physician for the treatment of a wide variety of conditions and illnesses; Pharmaceuticals prescribed or administered by a physician comprised of oligonucleotide compounds for the treatment of a wide variety of conditions and illnesses; Oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents prescribed or administered by a physician; drug delivery agents consisting of oligonucleotide compounds that facilitate delivery of a wide range of pharmaceuticals prescribed or administered by a physician
Research and development of oligonucleotide compounds for use in pharmaceutical therapies; Research and development of oligonucleotide delivery agents for use in pharmaceutical therapies; Research and development of oligonucleotide-based or -derived pharmaceuticals; Research and development of pharmaceuticals comprised of oligonucleotide compounds; Research and development of oligonucleotide delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical and therapeutic agents; Research and development of drug delivery agents consisting of oligonucleotide compounds
Oligonucleotide compounds for use in the manufacture of pharmaceutical therapies
Custom manufacture of oligonucleotides
